TY - JOUR
T1 - Initiation and discontinuation of hormone therapy for menopausal symptoms
T2 - Results from a community sample
AU - Bosworth, Hayden B.
AU - Bastian, Lori A.
AU - Grambow, Steven C.
AU - McBride, Colleen M.
AU - Skinner, Celette Sugg
AU - Fish, Laura
AU - Rimer, Barbara K.
AU - Siegler, Ilene C.
N1 - Funding Information:
This research is supported by a grant (P01-CA72099) from the National Cancer Institute and the first author is supported in part by the Department of Veterans Affairs, Veterans Health Administration, HSR&D Service, investigator initiative grant 20-034. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the National Cancer Institute.
PY - 2005/2
Y1 - 2005/2
N2 - Factors related to initiation and discontinuation of hormonal therapy (HT) for treatment of menopausal symptoms were examined in a community sample of 533 peri/postmenopausal women aged 45-54 by telephone three times. Over 40 variables including: sociodemographic characteristics, clinical reasons to start HT use, HT contraindications, HT attitudes/knowledge, and health behaviors were examined in logistic regression models comparing women who discontinued HT to women who continued using HT over 9 months (discontinuers) and women who initiated HT versus women who never used HT over 9 months (initiators). Increased understanding of HT, confidence, mental health symptoms, perception that menopause is natural, and having gynecological surgery were related to decreased likelihood of HT discontinuation. Increased understanding about risks of HT, vasomotor symptoms, mood symptoms, and having gynecological surgery were related to increased likelihood of HT Initiation. These findings highlight the importance of physicians discussing HT with their patients, particularly because of recent clinical trial developments.
AB - Factors related to initiation and discontinuation of hormonal therapy (HT) for treatment of menopausal symptoms were examined in a community sample of 533 peri/postmenopausal women aged 45-54 by telephone three times. Over 40 variables including: sociodemographic characteristics, clinical reasons to start HT use, HT contraindications, HT attitudes/knowledge, and health behaviors were examined in logistic regression models comparing women who discontinued HT to women who continued using HT over 9 months (discontinuers) and women who initiated HT versus women who never used HT over 9 months (initiators). Increased understanding of HT, confidence, mental health symptoms, perception that menopause is natural, and having gynecological surgery were related to decreased likelihood of HT discontinuation. Increased understanding about risks of HT, vasomotor symptoms, mood symptoms, and having gynecological surgery were related to increased likelihood of HT Initiation. These findings highlight the importance of physicians discussing HT with their patients, particularly because of recent clinical trial developments.
KW - Adherence
KW - Climacteric symptoms
KW - Hormonal replacement medication
KW - Menopause
KW - Patient-physician communication
UR - http://www.scopus.com/inward/record.url?scp=17444390045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17444390045&partnerID=8YFLogxK
U2 - 10.1007/s10865-005-2721-2
DO - 10.1007/s10865-005-2721-2
M3 - Article
C2 - 15887880
AN - SCOPUS:17444390045
SN - 0160-7715
VL - 28
SP - 105
EP - 114
JO - Journal of Behavioral Medicine
JF - Journal of Behavioral Medicine
IS - 1
ER -